CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
Guotou Securities: Maintains "buy" rating on SMOORE INTL (06969) as share repurchase demonstrates long-term confidence.
BOCI Securities: Reiterates over-weight rating on the natural uranium industry and expects long-term trade contracts to rebound in 2026.
HK Stock Market Move | CGN MINING (01164) surged by over 9% again, with the company's performance expected to benefit from the upward trend in uranium prices, production increases, and improvements in pricing mechanisms.
Guotou Securities: Maintains "buy" rating on SMOORE INTL (06969) as share repurchase demonstrates long-term confidence.
BOCI Securities: Reiterates over-weight rating on the natural uranium industry and expects long-term trade contracts to rebound in 2026.
HK Stock Market Move | CGN MINING (01164) surged by over 9% again, with the company's performance expected to benefit from the upward trend in uranium prices, production increases, and improvements in pricing mechanisms.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
